These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23265038)

  • 21. Extravascular leakage of induction doses of rocuronium: four cases in which both depth of neuromuscular block and plasma concentration of rocuronium were assessed.
    Takagi S; Kijima M; Iwasaki H; Doshu-Kajiura A; Kitajima O; Suzuki T
    J Clin Monit Comput; 2022 Apr; 36(2):587-592. PubMed ID: 33745069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report.
    Davis L; Jayarajah MJ; Toner CC; Flynn PJ
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():65-8. PubMed ID: 8557009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extremely prolonged neuromuscular blockade after rocuronium: a case report.
    Morales Martín AC; Vaquero Roncero LM; Muriel Villoria C
    Acta Anaesthesiol Scand; 2009 Aug; 53(7):957-9. PubMed ID: 19397500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of prolongation of rocuronium neuromuscular blockade in a pregnant patient receiving magnesium].
    Habe K; Kawasaki T; Sata T
    Masui; 2014 Jul; 63(7):817-9. PubMed ID: 25098146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of age on maintenance of intense neuromuscular block with rocuronium.
    Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
    Woloszczuk-Gebicka B; Wyska E; Grabowski T
    Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of neuromuscular block of atracurium and rocuronium in adults.
    Hans P; Brichant JF; Franzen A; Faleres X; Lamy M
    Acta Anaesthesiol Belg; 1996; 47(2):53-8. PubMed ID: 8869671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response relationship and time course of action of rocuronium bromide in perspective.
    Viby-Mogensen J
    Eur J Anaesthesiol Suppl; 1994; 9():28-32. PubMed ID: 7925205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In non-obese patients, duration of action of rocuronium is directly correlated with body mass index.
    Fujimoto M; Tanahira C; Nishi M; Yamamoto T
    Can J Anaesth; 2013 Jun; 60(6):552-6. PubMed ID: 23463483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex.
    Matsuki G; Takahata O; Iwasaki H
    Can J Anaesth; 2011 Aug; 58(8):769-70. PubMed ID: 21614668
    [No Abstract]   [Full Text] [Related]  

  • 33. Ephedrine delays rocuronium recovery.
    Piccioni F; Tramontano GT; Lassola S; Tognoli E; Langer M
    Can J Anaesth; 2013 Apr; 60(4):409-10. PubMed ID: 23344922
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys.
    Bostan H; Kalkan Y; Tomak Y; Tumkaya L; Altuner D; Yılmaz A; Erdivanli B; Bedir R
    Ren Fail; 2011; 33(10):1019-24. PubMed ID: 22013936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacology of rocuronium bromide (ORG 9426).
    Wicks TC
    AANA J; 1994 Feb; 62(1):33-8. PubMed ID: 8122487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced duration of muscle relaxation with rocuronium in a normocalcemic hyperparathyroid patient.
    Munir MA; Jaffar M; Arshad M; Akhter MS; Zhang J
    Can J Anaesth; 2003; 50(6):558-61. PubMed ID: 12826546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial comparing rocuronium priming, magnesium pre-treatment and a combination of the two methods.
    Kim MH; Oh AY; Jeon YT; Hwang JW; Do SH
    Anaesthesia; 2012 Jul; 67(7):748-54. PubMed ID: 22420830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia.
    Williamson RM; Mallaiah S; Barclay P
    Acta Anaesthesiol Scand; 2011 Jul; 55(6):694-9. PubMed ID: 21480829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.